Torsemide Tablets and Spironolactone Tablets — Competitive Intelligence Brief

Torsemide Tablets and Spironolactone Tablets (Torsemide Tablets and Spironolactone Tablets) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Loop diuretic and potassium-sparing diuretic. Area: Cardiovascular.

phase 3 Loop diuretic and potassium-sparing diuretic Sodium-chloride cotransporter and Mineralocorticoid receptor Cardiovascular Small molecule

Target snapshot

Torsemide Tablets and Spironolactone Tablets (Torsemide Tablets and Spironolactone Tablets) — Sarfez Pharmaceuticals, Inc.. Torsemide is a thiazide-like diuretic that works by inhibiting the sodium-chloride cotransporter in the distal convoluted tubule of the kidneys, leading to increased urine production and reduced fluid volume. Spironolactone is a potassium-sparing diuretic that works by antagonizing the mineralocorticoid receptor, leading to increased sodium excretion and reduced potassium loss.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Torsemide Tablets and Spironolactone Tablets TARGET	Torsemide Tablets and Spironolactone Tablets	Sarfez Pharmaceuticals, Inc.	phase 3	Loop diuretic and potassium-sparing diuretic	Sodium-chloride cotransporter and Mineralocorticoid receptor
Torsemide and Spironolactone tablet	Torsemide and Spironolactone tablet	Sarfez Pharmaceuticals, Inc.	phase 3	Loop diuretic and potassium-sparing diuretic	Sodium-potassium-chloride cotransporter (NKCC2) and Aldosterone receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Loop diuretic and potassium-sparing diuretic class)

1. Sarfez Pharmaceuticals, Inc. · 2 drugs in this class